Apixaban Market: The Rise of Next-Generation Anticoagulation Therapy
The global Apixaban market is experiencing a significant surge as healthcare providers shift away from traditional anticoagulants like warfarin. This growth is primarily fueled by the increasing prevalence of atrial fibrillation and deep vein thrombosis in an aging global population. Use cases for Apixaban often focus on stroke prevention and the treatment of pulmonary embolism, where its...
0 Commentarios 0 Acciones 80 Views 0 Vista previa